Showing 36,902 results

Filters
Side effects

Lipids improved by switching from ritonavir to cobicistat as a booster for darunavir

News
6 September 2017
Mental & emotional health problems

Case reports of severe dolutegravir-related depression

News
5 September 2017
PrEP science

Experts concur that event-related oral PrEP probably won’t work for women

News
1 September 2017
Sleep

Taking dolutegravir in the morning may avert insomnia

News
31 August 2017
Hepatitis C treatment

The availability of direct-acting antivirals is reducing disparities in the uptake of hepatitis C treatment

News
30 August 2017
Transgender people

Who are trans women acquiring HIV from?

News
29 August 2017
PrEP programmes & uptake

One in seven people offered PrEP in African study start it immediately

News
28 August 2017
Ageing & HIV

What is “successful ageing” for people living with HIV?

News
26 August 2017
HIV prevention policy

New South Wales reports record drop in HIV diagnoses: fewest this year since records began

News
25 August 2017
Generic medicines

No evidence of reduced efficacy or increased side-effects when patients switch to generic drugs, comparison study finds

News
24 August 2017
Drug interactions & pharmacokinetics

Trans women wary of antiretroviral drug and hormone interactions

News
23 August 2017
Menopause

Liver fibrosis speeds up around the menopause in women with HIV and HCV co-infection

News
22 August 2017
Health problems & ageing

People with HIV are at risk for liver fibrosis and steatosis

News
21 August 2017
Hepatitis C symptoms & diagnosis

Switching from efavirenz to raltegravir leads to significant improvements in fatty liver disease in people with HIV

News
17 August 2017
Cardiovascular disease

Peripheral artery disease more common in people with HIV with lower CD4 counts

News
15 August 2017
PrEP programmes & uptake

PrEP use in US exceeds 100,000 in Gilead pharmacy survey

News
14 August 2017
Cancer

Incidence of anal cancer has already peaked among HIV-positive gay men; reductions can be achieved with expanded ART coverage and screening

News
11 August 2017
Hepatitis C treatment

Treatment with DAAs reduces the risk of mortality in the first 18 months after the completion of treatment

News
10 August 2017
Changing treatment

Switch from boosted protease inhibitor to dolutegravir reduces lipids in people with HIV at higher risk of heart disease

News
9 August 2017
New & experimental HIV treatments

Boosted darunavir plus lamivudine matches three-drug regimen

News
8 August 2017
New & experimental hepatitis C treatment

European and US regulators approve AbbVie's new combo for all hepatitis C genotypes

News
7 August 2017
PrEP programmes & uptake

PrEP demand in England is rapidly accelerating – and most will want to join the trial

News
4 August 2017
The search for a cure

What marks out HIV controllers from others?

News
3 August 2017
The search for a cure

Why curing HIV may be like curing cancer – and may be as difficult

News
3 August 2017